• 1
    Epstein SE, Robinson BF, Kahler RL, Braunwald E. Effects of beta-adrenergic blockade on the cardiac response to maximal and submaximal exercise in man. J Clin Invest 1965; 44: 174553.
  • 2
    Joyner MJ, Freund BJ, Jilka SM, et al. Effects of betablockade on exercise capacity of trained and untrained men: a hernodynamic comparison. J Appl Physiol 1986; 60: 14291434.
  • 3
    Pearson SB, Banks DC, Patrick JM. The effects of beta-adrenoceptor blockade on factors affecting exercise tolerance in normal man. Br J Clin Pharmacol 1979; 8: 143148.
  • 4
    Ekblom B, Goldbarg N, Kilbom Å, Åstrand PO. Effects of atropine and propranolol on the oxygen transport system during exercise in man. Scand J Clin Lab Invest 1972; 30: 3542.
  • 5
    Reybrouck T, Amery A, Billiet L. Hemodynamic response to graded exercise after chronic beta-adrenergic blockade. J Appl Physiol 1977; 42(2): 133138.
  • 6
    Sklar J, Johnston GD, Overlie P, et al. The effects of a cardioselective (metoprolol) and a nonselective (propranolol) beta-adrenergic blocker on the response to dynamic exercise in normal men. Circulation 1982; 65: 894899.
  • 7
    Brodde O-E. β-1- and β-2-adrenoceptors in the human heart: Properties, function, and alterations in chronic heart failure. Pharmacol Rev 1991; 43: 203242.
  • 8
    Tarazi RC, Dustan HP. Beta adrenergic blockade in hypertension. Am J Cardiol 1972; 29: 633640.
  • 9
    Lund-Johansen P. Central haemodynamic effects of beta blockers in hypertension. A comparison between atenolol, metoprolol, timolol, penbutolol, alprenolol, pindolol and bunitrolol. Eur Heart J 1983; 4 Suppl D: 112.
  • 10
    Haggendal J, Hartley LH, Saltin B. Arterial noradrenaline concentration during exercise in relation to the relative work levels. Scand J Clin Lab Invest 1970; 26: 337342.
  • 11
    Freedman RR, Sabharwal SC, Desai N. Sex differences in peripheral vascular adrenergic receptors. Circ Res 1987; 61: 581585.
  • 12
    MacFarlane BJ, Hughson RL, Green HJ, Walters DJ, Ranney DA. Effsects of oral propranolol and exercise protocol on indices of aerobic function in normal man. Can J Physiol Pharmacol 1983; 61: 10101016.
  • 13
    Anderson RL, Wilmore JH, Joyner MJ, et al. Effects of cardioselective and nonselective beta-adrenergic blockade on the performance of highly trained runners. Am J Cardiol 1985; 55: 149D154D.
  • 14
    Gullestad L, Birkeland K, Nordby G, Larsen S, Kjekshus J. Effects of selective beta-2-adrenoceptor blockade on serum potassium and exercise performance in normal men. Br J Clin Pharmacol 1991; 32: 201207.
  • 15
    Froelicher VF, Brammell H, Davis G, Noguera I, Stewart A, Lancaster MC. A comparison of three maximal treadmill exercise protocols. J Appl Physiol 1974; 36: 720725.
  • 16
    Elia M, Livesey G. Theory and validity of indirect calometry during net lipid synthesis. Am J Clin Nutr 1988; 41: 591607.
  • 17
    Borg G. Perceived exertion as an indicator of somatic stress. Scand J Rehab Med 1970; 2: 9298.
  • 18
    Leenen FHH, Coenen CHM, Zonderland M, Maas AHJ. Effects of cardioselective and non-selective beta-blockade on dynamic exercise performance in mildly hypertensive men. Clin Pharmacol Ther 1980; 28: 1221.
  • 19
    Coltart DJ, Shand DG. Plasma propranolol levels in the quantitative assessment of beta-adrenergic blockade in man. Br Med J 1970; 3: 731734.
  • 20
    Walle T, Byington RP, Furberg C, McIntyre KM, Vokonas PS. Biological determinants of propranolol disposition: Results from 1308 patients in the Beta-blocker Heart Atack Trial. Clin Pharmacol Ther 1985; 38: 509518.
  • 21
    Anderson SD, Bye PTP, Perry CP, Hamor GP, Theobald G, Nyberg G. Limitation of work performance in normal adult males in the presence of beta-adrenergic blockade. Aust NZ J Med 1979; 9: 515520.
  • 22
    Walle T, Walle K, Cowart TD, Conradi EC. Pathway-selective sex differences in the metabolic clearance of propranolol in human subjects. Clin Pharmacol Ther 1989; 46: 257263.
  • 23
    Cleavland CR, Shand DG. Effect of route of administration on the relationship between beta–adrenergic blockade and plasma propranolol level. Clin Pharmacol Ther 1972; 13: 181185.
  • 24
    Wellstein A, Palm D, Wiemer G, Schafer-Korting M, Mutschler E. Simple and reliable radioreceptor assay for beta-adrenoceptor antagonists and active metabolites in native human plasma. Eur J Clin Pharmacol 1984; 27: 545553.
  • 25
    Pine M, Favrot L, Smith S, McDonald K, Chidsey CA. Correlation of plasma propranolol concentration with therapeutic response in patients with angina pectoris. Circulation 1975; 52: 886893.
  • 26
    Stone PH, Gibson RS, Glasser SP, et al. Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Circulation 1990 82: 19621972.
  • 27
    Wilcox RG, Bennett T, Macdonald IA, Herbert M, Skene AM. The effects of acute or chronic ingestion of propranolol or metoprolol on the physiological responses to prolonged, submaximal exercise in hypertension. Br J Clin Pharmacol 1984; 17: 273281.
  • 28
    Macdonald IA, Bennett T, Brown AM, Wilcox RG, Skene AM. The effects of acute or chronic ingestion of propranolol or metoprolol on the metabolic and hormonal responses to prolonged, submaximal exercise in hypertensive men. Br J Clin Pharmacol 1984; 17: 283293.
  • 29
    Brodde O-E. The functional importance of the beta1 and beta2 adrenoceptors in human heart. Am J Cardiol 1988; 62: 24C29C.
  • 30
    Brodde O-E, Michel MC, Wang X-L, Zerkowski H-R. Chronic beta-adrenoceptor antagonist treatment modulates human cardiac and vascular beta-adrenoceptor density in a subtype–selective fashion. J Hypertension 1988; 6 (Suppl 4): S497S500.
  • 31
    Wheeldon NM, Newnham DM, Coutie WJ, Peters JA, McDevitt DG, Lipworth BJ. Influence of sex-steroid hormones on the regulation of lymphocyte β2-adrenoceptors during the menstral cycle. Br J Clin Pharmacol 1994; 37: 583588.
  • 32
    Johansson SR, Hjalmarson A. Age and sex differences in cardiovascular reactivity to adrenergic agonists, mental stress and isometric exercise in normal subjects. Scand J Clin Lab Invest 1988; 48: 183191.
  • 33
    Kaiser P. Hylander B, Eliasson K, Kaijser L. Effect of beta-1-selective and nonselective beta blockade on blood pressure relative to physical performance in men with systemic hypertension. Am J Cardiol 1985; 55: 79D84D.
  • 34
    Smyth GA, Hughson RL, Walters DJ, Ranney DA. Short-versus long-term effects of oral beta blockers on exercise performance. J Cardiac Rehabil 1984; 4: 227237.
  • 35
    Paterson JW, Conolly ME, Dollery CT, Hayes A, Cooper RG. The pharmacodynamics and metabolism of propranolol in man. Pharmacol Clin 1970; 2: 127133.
  • 36
    Gullestad L, Hallén J, Sejersted OM. Variable effects of β-adrenoceptor blockade on muscle blood flow during exercise. Acta Physiol Scand 1993; 149: 257271.
  • 37
    Bevilacqua M, Savonitto S, Bosisio E, et al. Role of the Frank-Starling mechanism in maintaining cardiac output during increasing levels of treadmill exercise in beta-blocked men. Am J Cardiol 1989; 63: 853857.
  • 38
    Lund-Johansen P. Hemodynamic long-term effects of timolol at rest and during exercise in essential hypertension. Acta Med Scand 1976; 199: 263267.
  • 39
    Donald DE, Shepherd JT. Sustained capacity for exercise in dogs after complete cardiac denervation. Am J Cardiot 1964; 14: 853859.
  • 40
    Wilmore JH, Freund BJ, Joyner MJ, et al. Acute response to submaximal and maximal exercise consequent to beta adrenergic blockade: implication for the prescription of exercise. Am J Cardiol 1985; 55: 135D141D.
  • 41
    Parker GW, Michael LH, Hartley CJ, Skinner JE, Entman ML. Central beta-adrenergic mechanisms may modulate ischemic ventricular fibrillation in pigs. Circ Res 1990; 66 259270.
  • 42
    Åblad B, Bjurø T, Bjørrkman J-A, Edstrøm T, Olsson G. Role of central nervous beta-adrenoceptors in the prevention of ventricular fibrillation through augmention of cardiac vagal tone. J Am Coll Cardiol 1991; 17 (Suppl A): 251A.
  • 43
    Haggendal J, Johansson G, Jønsson L, Thoren-Tolling K. Effect of propranolol on myocardial cell necroses and blood levels of catecholamines in pigs subjected to stress. Acta Pharmacol Toxicol 1982; 50: 5866.
  • 44
    Petersen ES, Whipp BJ, Davis JA, Huntsman DJ, Brown H, Wasserman K. Effects of β-adrenergic blockade on ventilation and gas exchange during exercise in humans. J Appl Physiol 1983; 54: 13061313.
  • 45
    Mueller HS, Ayres SM, Religa A, Evans RG. Propranolol in the treatment of acute myocardial infarction. Circulation 1974; 49: 10781087.
  • 46
    Gullestad L, Dolva LO, Nordby G, Skaarads K, Larsen S, Kjekshus J. The importance of potassium and lactate for maximal exercise performance during beta blockade. Scand J Clin Lab Invest 1989; 49: 521528.
  • 47
    Hallén J, Gullestad L, Sejersted OM. K+ shifts of skeletal muscle during stepwise bicycle exercise with and without β-adrenoceptor blockade. J Physiol 1994; 477: 149159.
  • 48
    Sanchez J, Pequignot JM, Peyrin L, Monod H. Sex differences in the sympatho-adrenal response to isometric exercise. Eur J Appl Physiol 1980; 45: 147154.
  • 49
    Vendsalu A. Studies on adrenaline and noradrenaline in human plasma: VI-Plasma concentrations of adrenaline and noradrenaline during muscular work. Acta Physiol Scand 1960; 49 (Suppl 173): 5769.
  • 50
    Rahman ARA, McDevitt DG, Struthers AD, Lipworth BJ. Sex differences in hypokalaemic and electrocardiographic effects of inhaled terbutaline. Thorax 1992; 47: 10561059.
  • 51
    Johansson SR, Hjalmarson Å. Age and sex differences in cardiovascular reactivity to adrenergic agonists, mental stress and isometric exercise. Scand J Clin Lab Invest 1988; 48: 183191.